Skip Navigation

European Heart Journal 2001 22(13):1061-1062; doi:10.1053/euhj.2000.2574
Copyright © 2001 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Gustafsson, I.
Right arrow Articles by Hildebrandt, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gustafsson, I.
Right arrow Articles by Hildebrandt, P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorials

Blood glucose in the CCU: time to measure

I. Gustafsson and P. Hildebrandt

Department of Cardiology and Endocrinology, Frederiksberg University Hospital, Copenhagen, Denmark

References

  1. Malmberg K, Yusuf S, Gerstein HC. Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry. Circulation. 2000;102:1014–1019[Abstract/Free Full Text]
  2. Gu K, Cowie CC, Harris MI. Diabetes and decline in heart disease mortality in US adults. JAMA. 1999;281:1291–1297[Abstract/Free Full Text]
  3. McGuire DK, Emanuelsson H, Granger CB. Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb Study. Eur Heart J. 2000;21:1750–1758[Abstract/Free Full Text]
  4. Malmberg K, Ryden L, Efendic S. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol. 1995;26:57–65[Abstract]
  5. Oswald GA, Yudkin JS. Hyperglycaemia following acute myocardial infarction: the contribution of undiagnosed diabetes. Diabet Med. 1987;4:68–70[Web of Science][Medline]
  6. Madsen JK, Haunsøe S, Helquist S. Prevalence of hyperglycaemia and undiagnosed diabetes mellitus in patients with acute myocardial infarction. Acta Med Scand. 1986;220:329–332[Web of Science][Medline]
  7. Stubbs PJ, Laycock J, Alaghband-Zadeh J, Carter G, Noble MI. Circulating stress hormone and insulin concentrations in acute coronary syndromes: identification of insulin resistance on admission. Clin Sci (Colch). 1999;96:589–595[Medline]
  8. Husband DJ, Alberti KG, Julian DG. "Stress" hyperglycaemia during acute myocardial infarction: an indicator of pre-existing diabetes? Lancet. 1983;2:179–181[CrossRef][Medline]
  9. Tenerz , Lönnberg I, Berne C, Nilsson G, Leppert J. Myocardial infarction and prevalence of diabetes mellitus: Is increased casual blood glucose at admission a reliable criterion for the diagnosis of diabetes? Eur Heart J. 2001;22:1102–1110[Abstract/Free Full Text]
  10. Mainard F, Ozanne P, Madec Y. Variations in lipoproteins, hormones and blood glucose during the early acute phase of myocardial infarction. Atherosclerosis. 1988;69:225–231[CrossRef][Web of Science][Medline]
  11. Ravid M, Berkowicz M, Sohar E. Hyperglycemia during acute myocardial infarction. A six-year follow-up study. JAMA. 1975;233:807–809[Abstract/Free Full Text]
  12. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355:773–778[CrossRef][Web of Science][Medline]
  13. Chowdhury TA, Lasker SS. Elevated glycated haemoglobin in non-diabetic patients is associated with an increased mortality in myocardial infarction. Postgrad Med J. 1998;74:480–481[Abstract/Free Full Text]
  14. Fath-Ordoubadi F, Beatt KJ. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials. Circulation. 1997;96:1152–1156[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Gustafsson, I.
Right arrow Articles by Hildebrandt, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gustafsson, I.
Right arrow Articles by Hildebrandt, P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?